The Repeat Use Procedure slide deck looks at:
- What is a Repeat Use Procedure?
- Steps to consider
- What should be included in the dossier?
Further Reading
CMC & Pharmaceutical Regulatory Affairs Services
Our pharmaceutical regulatory affairs team is staffed by experts who have considerable expertise in the sector. Every team member has at least 15 years of experience in the pharmaceutical sector assisting pharmaceutical companies with their regulatory issues. Since 2002, our pharmaceutical regulatory affairs specialists have been working with clients all over the world. Read more about our team here.Can You Use A U.S. Dossier To Apply For A European Marketing Authorisation?
Is it possible to use a U.S. dossier when applying for an E.U. marketing authorisation? This is a question that is asked time and again. We first published this article in 2017. Below, we have updated it and included links to other relevant articles that will assist companies dealing with this issue. Read the article here.Marketing Authorisation Holders – An Overview
Acorn Regulatory’s consultants are experts in the sector. Members of our team have written extensively on this website and in other industry publications about the issues associated with marketing authorisations holders and much more. Below we have highlighted just four articles that our team members have written on the subject in recent times. Read the full article about Marketing Authorisation Holders here.Need A WDA? Read Our Step By Step Guide
There has been significant growth in the number of companies seeking a Wholesale Distribution Authorisation (WDA) in recent years. We have assisted many companies with every step of the process. Here, we outline a step by step guide for obtaining a WDA. Read the full article here.How To Prepare For A Pharmacovigilance Inspection
A pharmacovigilance inspection can be a daunting prospect for many companies. Since 2002 we have worked with countless companies to guide them through their inspections. We look at the measures that your company can take to be prepared. Read the full article here.How To Complete A Type I Variation
Type I Variations to a Marketing Authorisation are surprisingly difficult. The procedure that many people perceive to be a simple process can prove to be otherwise. This article looks at how to complete a type 1 variation and we will consider:- common deficiencies
- common validation issues
- the challenges posed by the eAF
- what to do when documentation is missing
- how to handle GMP variations
- what happens when a CEP is presented for an active substance instead of a GMP certificate